Maxwell Meng
@Uro_Max
Followers
380
Following
1K
Media
40
Statuses
336
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression | Nature Communications
nature.com
Nature Communications - Single cell analysis of histologic variant bladder tumors detects a shared CA125+ tumor cell state associated with aggressive clinical features and reveals enriched...
1
12
48
Yesssss! So fortunate to have @KShee11 match here for fellowship in Urologic Oncology @UCSFUrology
0
2
10
Dr. Washington an emerging leader in prostate cancer research has received the 2024 PCF Young Investigator Award! This prestigious recognition highlights his innovative research into the social factors influencing prostate cancer outcomes. @SamWashUro
https://t.co/8f7WhJykfr
5
11
88
Congratulations to Dr. Zachary Kornberg for matching with the UCSF UroOnc fellowship program. @drkornberg Welcome to the UCSF Urology family!
0
9
67
Excited to welcome @drkornberg back home to UCSF @UCSFUrology for fellowship in urologic oncology @SUO_YUO
1
2
15
Congratulations to our 13 new @UrologyCareFdn Research Scholar awardees! The UCF’s Research Scholar Awards support future research leaders and ensure they receive the necessary training and guidance for a successful research career. Learn more here ➡️ https://t.co/u71EJwlUAV
7
14
66
Meet @jonchou05 of @UCSFMedicine a recipient of a Bladder Cancer Advocacy Network's 2023 #BladderCancer Young Investigator Award. You can also read about the other recipients here: https://t.co/qC7yqIaEcw
2
5
30
We are pleased to announce the 2023 cohort of mentees for the #USMART Academy. We can ensure future success for #urology by equipping the next generation to give back to the urological research community. #AUA Click here ➡️ https://t.co/daAe3HLatH
11
12
92
Congrats to our team in Milano at #eau23, @RenuEapen presenting #LuTectomy trial data in packed Plenary @PeterMacCC
0
6
42
Save-the-Date! UroOnc Fellowship Virtual Open House 🗓️Thursday, 1/26/2023 ⏰5:00PM-6:00PM PST ✍️Register here: https://t.co/Ht1lv4aYcF
@Uro_Max @SimaPorten
0
3
2
Very proud of this 💫 of @USANZUrology Congratulations @RenuEapen so very well deserved 🥳@declangmurphy @DrMHofman @OconnellProf @PeterMacCC
15
11
74
Check out our @NatRevUrol review to learn how prostate cancer cells hijack naturally occurring cell stress coping mechanisms for their own benefit and how this could be targeted for therapy! @KShee11 @HeikoYangMDPhD @PeterLonergan @haognguyen @UCSFUrology
https://t.co/DjM3rWqn8l
2
10
48
Join us for the @UCSFUrology Residency Virtual Open House! 🗓️Monday, 8/22/2022 ⏰5:30-6:30PST ✍️Register Here: https://t.co/pYbBbPAzX2
@ben_breyer @lindsayahampson @SamWashUro @AShindelGHI
0
7
20
0
2
20
The UCSF Dept. of Urology is recruiting! Click the link(s) below to learn more. https://t.co/1wjqSTyZ9V
https://t.co/2Nz9BrrL6y
https://t.co/fRc2MIen5P
https://t.co/MDjL7Os0B2
0
4
13
Welcome Class of 2028! James Nie, MD, MBA @jamesnie93 Leah Ibrahim Puri, MD, MA @leahipuri Grace Lee, MD @grace_syl Emily Hacker, MD @hacker_emc
1
7
68
Everolimus did not show a significant DFS or OS advantage in adjuvant RCC. This study probably draws a line under the investigation of mTOR (TORC1/2) in RCC and draws a line under adjuvant targeted therapies in RCC. Everolimus role is relatively limited. #ASCO22
3
30
108